Rita Balice-Gordon
FounderFounder at Muna Therapeutics
Philadelphia, Pennsylvania, United States
FoundedMuna Therapeutics
About
Rita Balice-Gordon, Ph.D., is the Principal of Saperis Advisors, LLC, a strategic advisory firm focused on drug discovery, development, and biotech creation, and serves as an independent director on the boards of Muna Therapeutics, Lundbeck, and Collegium Pharmaceutical. She previously held roles including Chief Executive Officer of Muna Therapeutics, Global Head of Rare and Neurologic Diseases Research at Sanofi, and Vice-President and Head of Circuits, Neurotransmitters and Signaling at Pfizer, and earlier served as Professor of Neuroscience and Chair of the Neuroscience Graduate Group at the University of Pennsylvania, where she holds an adjunct appointment. She has authored more than 100 scientific papers, received NIH funding for over 30 years, and is an elected Fellow of the American Association for the
Founder at Muna Therapeutics
Intro paths
→
In turn, Rita can intro founders to Muna Therapeutics's investors below.
Experience
- Muna Therapeutics ApSIndependent Director, Board of Directorscurrent2026 — presentCopenhagen, Denmark
- Collegium Pharmaceutical, Inc.Director, Board of Directorscurrent2020 — presentBoston, Massachusetts, United States
- Perelman School of Medicine at the University of PennsylvaniaAdjunct Professor of Neurosciencecurrent2014 — presentPhiladelphia, PA
- Perelman School of Medicine at the University of PennsylvaniaProfessor of Neuroscience and Chair, Neuroscience Graduate Group1994 — 2014Philadelphia, PA
- LundbeckDirector, Board of Directorscurrent2026 — presentCopenhagen, Capital Region of Denmark, Denmark
- Muna TherapeuticsChief Executive Officer2021 — 2026Copenhagen, Denmark / Aarhus, Denmark / Leuven, Belgium / Philadelphia, PA USA
- Muna TherapeuticsChief Scientific Officer2020 — 2021
- Capsida BiotherapeuticsDirector, Board of Directors2021 — 2026Thousand Oaks, California, United States
- Novo Holdings / Novo SeedsEntrepreneur-In-Residence2020 — 2021
- SanofiGlobal Head, Rare and Neurologic Diseases Therapeutic Area2018 — 2020Boston and Paris
- SanofiGlobal Head, Neuroscience Therapeutic Area2016 — 2018Boston and Paris
- PfizerVice-President and Head, Circuits, Neurotransmitters and Signaling2012 — 2016Cambridge, MA
Skills & more
Neuroscience99Translational Research53Autoimmune Diseases11Neuromuscular Disorders9CNS disorders12Cell Biology43Life Sciences24Molecular Biology64Psychiatry26Drug Development14Biochemistry25Translational Medicine29
+11 more
Animal ModelsConfocal MicroscopyImmunohistochemistryGeneticsCell CultureResearchIn VivoNeurodegenerationCognitionSynapse formationSynapse plasticityLanguages English · Italian · Spanish
From Rita's professional profile.
Frequently asked questions
- Who is Rita Balice-Gordon?
- Rita Balice-Gordon, Ph.D., is the Principal of Saperis Advisors, LLC, a strategic advisory firm focused on drug discovery, development, and biotech creation, and serves as an independent director on the boards of Muna Therapeutics, Lundbeck, and Collegium Pharmaceutical. She previously held roles including Chief Executive Officer of Muna Therapeutics, Global Head of Rare and Neurologic Diseases Research at Sanofi, and Vice-President and Head of Circuits, Neurotransmitters and Signaling at Pfizer, and earlier served as Professor of Neuroscience and Chair of the Neuroscience Graduate Group at the University of Pennsylvania, where she holds an adjunct appointment. She has authored more than 100 scientific papers, received NIH funding for over 30 years, and is an elected Fellow of the American Association for the
- Where does Rita Balice-Gordon work?
- Rita Balice-Gordon is Founder of Muna Therapeutics.
- What companies did Rita Balice-Gordon found?
- Rita Balice-Gordon founded Muna Therapeutics.
- Where did Rita Balice-Gordon go to school?
- Rita Balice-Gordon studied at Washington University School of Medicine in St. Louis (Postdoctoral Fellow, Neuroscience); The University of Texas at Austin (Doctor of Philosophy (Ph.D.), Neurobiology); University of Chicago (Neuroscience).
Founder mafias
The University of Texas at Austin mafia189
Also came through, then founded or led a company.
Philip KrimMinorFounded Electron X +2Michael GortonPhysics & Engineering w minor in EnglishFounded Principal Solar +2Michael RoyzenBachelor of Science - BSFounded Smartlens +2Amar SawhneyM.S. and PhDFounded Access Closure +2Joah SpearmanBachelor of Science - BSFounded SXSW +2Arlo GilbertPolitical ScienceFounded Osano +1
+ 182 more
University of Chicago mafia136
Also came through, then founded or led a company.
Alexis BorisyBachelor's degreeFounded Foundation Medicine +2Bobby PittmanMaster's degreeFounded Oathafrica +2Sean HarperABFounded TransFS +2Bharat KilaruBachelor of Arts (BA)Founded Verano Health +2James Peyer, PhDBachelor of Arts (B.A.)Founded Rapalogix Health +2Matt KrisiloffFounded Preventive +1
+ 129 more
Northwestern University mafia134
Also came through, then founded or led a company.
Chris SchuhDoctor of Philosophy - PhDFounded Xtalic +2Lyle BerkowitzFounded Apollo Health +1Jeffrey LiuBachelor of Science - BSFounded Guavapass +1Sheridan ClayborneB.S (Dropped Out)Founded Lendtable +1Andy RinkGeneral Surgery Residency ProgramFounded Playgroundpediatrics +1Colton DillionBSFounded Quip Network +1
+ 127 more
Washington University School of Medicine in St. Louis mafia9
Also came through, then founded or led a company.
Reid HuberPhDFounded MOMA Therapeutics +2Ansuman SatpathyDoctor of Medicine (M.D.)Founded Santa Ana Bio +2Nicholas GoldnerDoctor of PhilosophyFounded Viosera +1Ben ScruggsPhDFounded Altis BiosystemsDave MessinaMaster of Science (MS)Founded Cofactor GenomicsRuss LebovitzMDFounded Ampriondx
+ 2 more
Same school
Also attended Washington University School of Medicine in St. Louis17
Reid HuberPartner at Third Rock VenturesDavid CohnInterim Chief Executive Officer and Chief Medical Officer at Oncology VenturesGlenn PierceScientific Advisory Group Co-Chair at Pathway to CuresBen ScruggsPartner at Hatteras Venture PartnersDaguang WangManaging Director at Yonjin Venture LLCDave VreelandSenior Managing Partner at Caduceus Capital Partners
+ 11 more
Also attended The University of Texas at Austin569
Michael DellFounder & CEO of Dell TechnologiesViswa SankaranarayananVenture Partner at Monta Vista CapitalTodd KleinManaging Partner, Revolution Growth at RevolutionSapna MehtaInvestor at RevolutionAnish AggarwalInvestor at LightbankAndrew ScottSenior Finance Manager at Greycroft
+ 563 more
Also attended University of Chicago474
Mark SusterManaging Partner at Upfront VenturesShardul ShahInvestor at Index VenturesSam BlackmanEntrepreneur in Residence at GV (Google Ventures)Clay FisherInvestor at Spark CapitalRolanda FuInvestor at Madrona Venture GroupJonas CiplickasPrincipal at Scale Venture Partners
+ 468 more
Also attended Northwestern University486
Mikowai AshwillInvestor at Spark CapitalNaomi Pilosof IonitaBoard Partner at Menlo VenturesEric OngInvestor at LightbankBill PescatelloInvestor at LightbankScott JacobsonManaging Director at Madrona Venture GroupAnna WangAssociate at March Capital Partners
+ 480 more
Shared employers
Also worked at Perelman School of Medicine at the University of Pennsylvania20
Eric ShanAssociate at 7wire VenturesTimothy ChangManaging Director at Goodwater CapitalMichael KalosInvestor at 82VSConnie LiPrincipal at F-Prime Capital PartnersNikhil AnanthPrincipal at F-Prime Capital PartnersShreeram AradhyeInvestor at Novartis Venture Fund
+ 14 more
Also worked at Lundbeck11
Christian Krog-JensenInvestor at Almi InvestJørgen Søberg PetersenSenior Partner at Novo HoldingsCamilla Petrycer HansenPartner at Novo HoldingsEric FloydRegulatory Advisor at 2Flo VenturesErik SteffensenExpert advisor at VÅR VenturesNicolas FavreChief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund
+ 5 more
Also worked at Muna Therapeutics4
Also worked at Sanofi130
Steve LiapisManaging Director at Northpond VenturesWalter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE Ventures
)
+ 124 more